Vitamin D Endocrine System and COVID-19

Area of Science:

• Endocrinology
• Immunology
• Infectious Diseases

Background:

• The vitamin D endocrine system (VDES) has known extraskeletal effects, influencing immune and cardiovascular cells.
• Vitamin D receptor expression is found in lung cells, suggesting a role in respiratory health.
• A good vitamin D status may offer protective mechanisms against severe outcomes of SARS-CoV-2/COVID-19 infection.

Purpose of the Study:

• To investigate the potential beneficial effects of the vitamin D endocrine system on the severity of COVID-19.
• To evaluate the impact of vitamin D status and supplementation on COVID-19 outcomes, including intensive care admission and mortality.

Main Methods:

• Review of preclinical data on VDES and extraskeletal effects.
• Meta-analysis of observational studies examining vitamin D status and COVID-19 outcomes.
• Analysis of pilot and retrospective studies on calcifediol and vitamin D administration in hospitalized COVID-19 patients.

Main Results:

• Observational data indicate that better vitamin D status is associated with reduced intensive care requirements and mortality.
• A pilot study showed a drastic reduction in intensive care admission with early high-dose calcifediol.
• Retrospective studies confirmed that calcifediol or vitamin D prescription before hospital admission decreased 30-day mortality in COVID-19 patients.

Conclusions:

• Adequate vitamin D status appears to have beneficial effects on the course of COVID-19.
• Rapid correction of 25-hydroxyvitamin D (25OHD) deficiency is recommended for individuals exposed to SARS-CoV-2.
• Large randomized trials are needed to confirm these findings, but current evidence supports intervention.